Australia markets close in 3 hours 36 minutes

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.99+0.27 (+4.72%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close5.72
Open5.82
Bid5.98 x 4000
Ask5.99 x 42300
Day's range5.34 - 6.00
52-week range3.36 - 14.70
Volume9,497,212
Avg. volume8,184,052
Market cap2.358B
Beta (5Y monthly)2.35
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Amarin (AMRN) Q4 2020 Earnings Call Transcript
    Motley Fool

    Amarin (AMRN) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Amarin (NASDAQ: AMRN)Q4 2020 Earnings CallFeb 25, 2021, 7:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to Amarin Corporation's conference call to discuss its fourth quarter and full-year 2020 financial results and operational updates.

  • Amarin (AMRN) Q4 Earnings & Revenues Top, Vascepa Sales Solid
    Zacks

    Amarin (AMRN) Q4 Earnings & Revenues Top, Vascepa Sales Solid

    Amarin's (AMRN) revenue growth in the fourth quarter is attributable to continued demand for its cardiovascular drug, Vascepa.

  • How Amarin Beat Wall Street's Q4 Estimates
    Motley Fool

    How Amarin Beat Wall Street's Q4 Estimates

    The drugmaker topped analysts' top- and bottom-line expectations despite challenges from a generic rival and the pandemic.